Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Tapia

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Scientific Reports|April 28, 2023
MIDO GDM: an innovative artificial intelligence-based prediction model for the development of gestational diabetes in Mexican womenHéctor Gallardo-Rincón, María Jesús Ríos-Blancas, Janinne Ortega-Montiel, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2024
Prediabetes as a risk factor for all-cause and cause-specific mortality: a prospective analysis of 115,919 adults without diabetes in Mexico CityCarlos A Fermín-Martínez, Omar Yaxmehen Bello-Chavolla, César Daniel Paz-Cabrera, et al.
Pathogens (Basel, Switzerland)|March 29, 2023
The Low Variability of Tc24 in <i>Trypanosoma cruzi</i> TcI as an Advantage for Chagas Disease Prophylaxis and Diagnosis in MexicoIngeborg Becker, Haydee Miranda-Ortiz, Edith A Fernández-Figueroa, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I TrialNaseema Gangat, Christian Marinaccio, Ronan Swords, et al.
Therapeutic Advances in Infectious Disease|January 21, 2022
Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico CityRosa María Wong-Chew, Edwin Xchel Rodríguez Cabrera, Carlos Alberto Rodríguez Valdez, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Therapeutic Advances in Infectious Disease|September 2, 2021
Impact of preemptive hospitalization on health outcomes at the temporary COVID-19 hospital in Mexico City: a prospective observational studyRafael Ricardo Valdez Vazquez, Héctor Gallardo-Rincón, Julieta Lomelín-Gascon, et al.
Frontiers in Immunology|September 1, 2022
Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort studyJiram Torres-Ruiz, Julieta Lomelín-Gascón, Ana Sofía Vargas-Castro, et al.
Infectious Diseases (London, England)|January 13, 2023
Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot studyJiram Torres-Ruiz, Julieta Lomelín-Gascón, Jaquelin Lira Luna, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Scientific Reports|April 28, 2023
MIDO GDM: an innovative artificial intelligence-based prediction model for the development of gestational diabetes in Mexican womenHéctor Gallardo-Rincón, María Jesús Ríos-Blancas, Janinne Ortega-Montiel, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2024
Prediabetes as a risk factor for all-cause and cause-specific mortality: a prospective analysis of 115,919 adults without diabetes in Mexico CityCarlos A Fermín-Martínez, Omar Yaxmehen Bello-Chavolla, César Daniel Paz-Cabrera, et al.
Pathogens (Basel, Switzerland)|March 29, 2023
The Low Variability of Tc24 in <i>Trypanosoma cruzi</i> TcI as an Advantage for Chagas Disease Prophylaxis and Diagnosis in MexicoIngeborg Becker, Haydee Miranda-Ortiz, Edith A Fernández-Figueroa, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I TrialNaseema Gangat, Christian Marinaccio, Ronan Swords, et al.
Therapeutic Advances in Infectious Disease|January 21, 2022
Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico CityRosa María Wong-Chew, Edwin Xchel Rodríguez Cabrera, Carlos Alberto Rodríguez Valdez, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Therapeutic Advances in Infectious Disease|September 2, 2021
Impact of preemptive hospitalization on health outcomes at the temporary COVID-19 hospital in Mexico City: a prospective observational studyRafael Ricardo Valdez Vazquez, Héctor Gallardo-Rincón, Julieta Lomelín-Gascon, et al.
Frontiers in Immunology|September 1, 2022
Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort studyJiram Torres-Ruiz, Julieta Lomelín-Gascón, Ana Sofía Vargas-Castro, et al.
Infectious Diseases (London, England)|January 13, 2023
Novel clinical and immunological features associated with persistent post-acute sequelae of COVID-19 after six months of follow-up: a pilot studyJiram Torres-Ruiz, Julieta Lomelín-Gascón, Jaquelin Lira Luna, et al.
Pageof 14